Skip to content

An Exploratory Investigation of a Male Focused Skincare Supplement

An Exploratory Investigation of a Male Focused Skincare Supplement

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05319847
Enrollment
38
Registered
2022-04-08
Start date
2022-04-15
Completion date
2022-06-30
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne, Skin Abnormalities

Brief summary

Most skincare products on the market are topical and do not take a holistic approach to understanding skin health. This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective. Research has previously supported the link between the gut microbiome and skin health and the supplement tested in this trial will further the knowledge on the effectiveness of supporting gut health to improve skin outcomes.

Interventions

DIETARY_SUPPLEMENTDaily Skin Supplement - Fountain of Youth

Skincare supplement

Sponsors

Citruslabs
CollaboratorINDUSTRY
Let's Disco
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open Label, Single Group Design

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Male * Between the ages of 18-55 * Frequently experience different forms of acne * Frequently experience breakouts * Must be in good health with no long term health conditions * BMI must be under 40 * Must follow a consistent dietary regimen * Must be willing to stop any oral supplementation targeting their skin while in the trail

Exclusion criteria

* Anyone who does take prescription medication (oral or topical) targeting their skin including reinoid, over the counter retinol, or retinal * Not willing to stop any oral supplementation targeting their skin * Severe chronic conditions, including oncological and psychiatric disorders * Previous severe allergic reactions * Unwilling the follow the study protocol

Design outcomes

Primary

MeasureTime frameDescription
Adult Acne12 weekChange in overall frequency and intensity of adult acne (Likert Scale 0-5 with higher scores representing a reduction in the appearance of adult acne)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026